This inventor holds 2 USPTO granted patents. Top assignee: Hongene Biotech Corporation. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2026
Title: Michael Su: Innovator in Functionalized N-acetylgalactosamine Analogs
Introduction
Michael Su is an accomplished inventor based in Union City, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of functionalized N-acetylgalactosamine analogs. His innovative work has the potential to impact therapeutic delivery systems.
Latest Patents
Michael Su holds 1 patent for his invention titled "Functionalized N-acetylgalactosamine analogs." This patent relates to the creation of mono or trivalent N-acetylgalactosamine analogs, which can be synthesized using various linkers containing functional groups. These analogs are particularly useful in the targeted delivery of oligonucleotide-based therapeutics.
Career Highlights
Throughout his career, Michael has demonstrated a strong commitment to advancing biotechnological research. His work at Hongene Biotech Corporation has positioned him as a key player in the development of innovative therapeutic solutions.
Collaborations
Michael has collaborated with notable colleagues, including Gang Zhao and Aldrich N K Lau, to further enhance the impact of his research and inventions.
Conclusion
Michael Su's contributions to the field of biotechnology, particularly through his patent on functionalized N-acetylgalactosamine analogs, highlight his role as an innovative inventor. His work continues to pave the way for advancements in targeted therapeutic delivery systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile